Abstract:Background Hepatocellular carcinoma (HCC) presents one of the major health threats in China today. A better understanding of the molecular genetics underlying malignant transformation of hepatocytes is critical to success in the battle against this disease. The methylation state of C5 of the cytosine in the CpG di-nucleotide that is enriched within or near the promoter region of over 50 % of the polymerase II genes has a drastic effect on transcription of these genes. Changes in the methylation profile of the promoters represent an alternative to genetic lesions as causative factors for the tumor-specific aberrant expression of the genes. Methods We have used the methylation specific PCR method in conjunction with DNA sequencing to assess the methylation state of the promoter CpG islands of twenty genes. Aberrant expression of these genes have been attributed to the abnormal methylation profile of the corresponding promoter CpG islands in human tumors. Results While the following sixteen genes remained the unmethylated in all tumor and normal tissues: CDH1, APAF1, hMLH1, BRCA1, hTERC, VHL, RARβ, TIMP3, DAPK1, SURVIVIN, p14 ARF , RB1, p15 INK4b , APC, RASSF1c and PTEN, varying degrees of tumor specific hypermethylation were associated with the p16 INK4a , RASSF1a, CASP8 and CDH13 genes. For instance, the p16 INK4a was highly methylated in HCC (17/29, 58.6%) and less significantly methylated in non-cancerous tissue (4/29. 13.79%). The RASSF1a was fully methylated in all tumor tissues (29/29, 100%), and less frequently methylated in corresponding non-cancerous tissue (24/29, 82.75%). Conclusions Furthermore, co-existence of methylated with unmethylated DNA in some cases suggested that both genetic and epigenetic (CpG methylation) mechanisms may act in concert to inactivate the p16 INK4a and RASSF1a in HCC. Finally, we found a significant association of cirrhosis with hypermethylation of the p16 INK4a and hypomethylation of the CDH13 genes. For the first time, the survey was carried out on such an extent that it would not only provide new insights into the molecular mechanisms underscoring the aberrant expression of the genes in this study in HCC, but also offer essential information required for a good methylation-based diagnosis of HCC.

[Aberrant Methylation of Multiple Genes and Its Clinical Implication in Hepatocellular Carcinoma].

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Detecting abnormal methylation of tumor suppressor genes GSTP1 , P16 , RIZ1 , and RASSF1A in hepatocellular carcinoma and its clinical significance.

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma.

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

The Association Between Methylation Patterns of DNAH17 and Clinicopathological Factors in Hepatocellular Carcinoma

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.

Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Methylation Profile of the Promoter CpG Islands of 14 “Drug-Resistance” Genes in Hepatocellular Carcinoma

Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs

Meta-Analysis Of Dna Methylation Biomarkers In Hepatocellular Carcinoma

Contribution of DNA methylation to the risk of hepatitis C virus-associated hepatocellular carcinoma: A meta-analysis

An aberrant DNA methylation signature for predicting hepatocellular carcinoma

Quantitative Analysis of APC Promoter Methylation in Hepatocellular Carcinoma and Its Prognostic Implications

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma

Quantitative Methylation Analysis of Multiple Genes Using Methylation-Sensitive Restriction Enzyme-Based Quantitative PCR for the Detection of Hepatocellular Carcinoma.

Aberrant Dna Methylation Profile of Hepatocellular Carcinoma and Surgically Resected Margin

Hypermethylation of Multiple Tumor-Related Genes in Gastric Carcinoma and Adjacent Normal Tissues

Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.